John Anto Pulikkan - Concepedia

Author

John Anto Pulikkan

University of Massachusetts Chan Medical School ORCID

Also Known As

J A Pulikkan, J. A. Pulikkan, J. Pulikkan, John A Pulikkan, John A. Pulikkan, John Anto Pulikkan, John Pulikkan, Pulikkan, John Anto

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Massachusetts Chan Medical School Martin Luther University Halle-Wittenberg Harvard University National University of Singapore Harvard Stem Cell Institute

About

John Anto Pulikkan is an author at University of Massachusetts Chan Medical School specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	260
2	Cell Biology	3	3	260
3	Natural Sciences	1	1	31
4	Biochemistry	1	1	31
5	Cellular Physiology	1	1	54

John Anto Pulikkan

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia John Anto Pulikkan, Viola Dengler, Philomina Sona Peramangalam, Blood	2009	278
C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations John Anto Pulikkan, Philomina Sona Peramangalam, Viola Dengler, Blood	2010	124
A small-molecule inhibitor of the aberrant transcription factor CBFβ-SMMHC delays leukemia in mice Anuradha Illendula, John Anto Pulikkan, Hongliang Zong, Science Hematological MalignancyCancer ResearchAdult LeukemiaCell RegulationMedicine	2015	113
Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers Anuradha Illendula, Jane Gilmour, Jolanta Grembecka, EBioMedicine	2016	99
CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia John Anto Pulikkan, Mahesh Hegde, Hafiz Mohd Ahmad, Cell Hematological MalignancyChromatinMyc Chromatin DynamicsAcute Myeloid LeukemiaApoptosis	2018	93
RUNX1 is required for oncogenic Myb and Myc enhancer activity in T-cell acute lymphoblastic leukemia AHyun Choi, Anuradha Illendula, John Anto Pulikkan, Blood	2017	83
Target proteins of C/EBPαp30 in AML: C/EBPαp30 enhances sumoylation of C/EBPαp42 via up-regulation of Ubc9 M. Geletu, Mumtaz Yaseen Balkhi, Abdul Ali Peer‐Zada, Blood	2007	70
Elevated PIN1 expression by C/EBPα-p30 blocks C/EBPα-induced granulocytic differentiation through c-Jun in AML John Anto Pulikkan, Viola Dengler, Abdul Ali Peer‐Zada, Leukemia InflammationPin1 ExpressionCell RegulationLymphocyte DevelopmentCell Signaling	2010	54
Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling John Anto Pulikkan, Dmitri Madera, Liting Xue, Blood	2012	52
NrasG12D oncoprotein inhibits apoptosis of preleukemic cells expressing Cbfβ-SMMHC via activation of MEK/ERK axis Liting Xue, John Anto Pulikkan, Peter J.M. Valk, Blood	2014	31

Page 1